Role of Sp1 in atherosclerosis

JF Jiang, ZY Zhou, YZ Liu, L Wu, BB Nie… - Molecular Biology …, 2022 - Springer
Specificity protein (Sp) is a famous family of transcription factors including Sp1, Sp2 and
Sp3. Sp1 is the first one of Sp family proteins to be characterized and cloned in mammalian …

[HTML][HTML] “Big Data” approaches for prevention of the metabolic syndrome

X Jiang, Z Yang, S Wang, S Deng - Frontiers in Genetics, 2022 - frontiersin.org
Metabolic syndrome (MetS) is characterized by the concurrence of multiple metabolic
disorders resulting in the increased risk of a variety of diseases related to disrupted …

[HTML][HTML] Genetically personalised organ-specific metabolic models in health and disease

C Foguet, Y Xu, SC Ritchie, SA Lambert… - Nature …, 2022 - nature.com
Understanding how genetic variants influence disease risk and complex traits (variant-to-
function) is one of the major challenges in human genetics. Here we present a model-driven …

[HTML][HTML] Network analysis of atherosclerotic genes elucidates druggable targets

SK Banik, S Baishya, A Das Talukdar… - BMC medical …, 2022 - Springer
Background Atherosclerosis is one of the major causes of cardiovascular disease. It is
characterized by the accumulation of atherosclerotic plaque in arteries under the influence …

Фиброзный процесс при атеросклерозе

ЯШ Шварц, ЕА Чересиз - Атеросклероз, 2022 - ateroskleroz.elpub.ru
Аннотация В обзоре приводятся современные представления о вариантах развития
атеросклеротического повреждения сосудов, дается описание атерогенеза как …

Genetically personalised organ-specific metabolic models in health and disease

C Foguet Coll, Y Xu, S Ritchie, S Lambert, E Persyn… - 2022 - repository.cam.ac.uk
Understanding how genetic variants influence disease risk and complex traits (variant-to-
function) is one of the major challenges in human genetics. Here we present a model-driven …

Primär genetische Dyslipoproteinämien und Atheroskleroserisiko

KO Schwab, J Doerfer - Pädiatrische Fettstoffwechselstörungen und …, 2022 - Springer
In diesem Kapitel werden alle wichtigen angeborenen Dyslipoproteinämien bei Kindern und
Jugendlichen behandelt und klinisch relevante Informationen über Hypercholesterinämien …